This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur Korea, St Pharm Co., Ltd.. Active years: 2021.
Company Filing History:
1 out of 12 
1 out of 19 
Years Active: 2021
Title: Sun Ju Kong: Innovator in Antiviral Compounds
Introduction
Sun Ju Kong is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work focuses on creating novel compounds that can effectively combat viral infections, specifically influenza.
Latest Patents
Sun Ju Kong holds a patent for a heteroaryl compound, its enantiomer, diastereomer, or pharmaceutically acceptable salt, along with an antiviral composition containing the same as an active ingredient. This invention is particularly noteworthy as it demonstrates remarkable antiviral activity against influenza viruses while exhibiting low cytotoxicity. This characteristic ensures minimal adverse effects on the human body, making it a promising candidate for the prevention and treatment of influenza virus-related diseases.
Career Highlights
Throughout his career, Sun Ju Kong has worked with esteemed organizations such as Institut Pasteur Korea and St Pharm Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in antiviral therapies.
Collaborations
Sun Ju Kong has collaborated with talented individuals, including Ji Young Min and Ji Hye Lee. These partnerships have enhanced his research efforts and contributed to the advancement of antiviral drug development.
Conclusion
Sun Ju Kong's innovative work in developing antiviral compounds positions him as a key figure in the pharmaceutical industry. His contributions have the potential to significantly impact public health by providing effective treatments for influenza virus infections.